Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Krzysztof Chojnowski
Observed names:
K Chojnowski,
K. CHOJNOWSKI,
K. Chojnowski
Institution:
Copernicus Memorial Hospital
Observed institutions:
Medical University of Warsaw,
Copernicus Memorial Hospital,
Medical University of Lodz,
Central Clinical Hospital,
The Maria Sklodowska-Curie National Research Institute of Oncology,
University of Warsaw
show all 6
ORCID:
0000-0002-5154-9744
Observed ORCID:
0000-0002-5154-9744
OpenAlex ID:
A5031250383
Phase 3 randomised study of avatrombopag, a novel thrombopoietin receptor agonist for the treatment of chronic immune thrombocytopenia
2018
·
Wojciech Jurczak
, Krzysztof Chojnowski
, et al.
·
British Journal of Haematology
·
244
PDF
Association of tumor necrosis factor and human leukocyte antigen DRB1 alleles with Graves' ophthalmopathy
2004
·
Tomasz Bednarczuk
, Yuji Hiromatsu
, et al.
·
Human Immunology
·
53
Rituximab combined with cladribine or with cladribine and cyclophosphamide in heavily pretreated patients with indolent lymphoproliferative disorders and mantle cell lymphoma
2006
·
Tadeusz Robak
, Piotr Smolewski
, et al.
·
Cancer
·
49
Assessment of Coagulation Disorders in Patients with Acute Leukemia Before and After Cytostatic Treatment
1999
·
Krzysztof Chojnowski
, Ewa Wawfuyniak
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
34
Hemostatic changes after 1 month of thalidomide and dexamethasone therapy in patients with multiple myeloma
2012
·
Marta Robak
, Jacek Treliński
, et al.
·
Medical Oncology
·
33
PDF
Activation of blood coagulation and the activity of cancer procoagulant (EC 3.4.22.26) in breast cancer patients
1999
·
Wojciech P. Mielicki
, Michal Tenderenda
, et al.
·
Cancer Letters
·
32
Association of interferon gamma, tumor necrosis factor alpha and interleukin 6 serum levels with systemic lupus erythematosus activity.
1998
·
E Robak
, A Sysa-Jedrzejewska
, et al.
·
PubMed
·
32
Circulating endothelial cells in essential thrombocythemia and polycythemia vera: correlation with JAK2-V617F mutational status, angiogenic factors and coagulation activation markers
2010
·
Jacek Treliński
, Agnieszka Wierzbowska
, et al.
·
International Journal of Hematology
·
31
Impact of Screening Kindreds for SDHD p.Cys11X as a Common Mutation Associated with Paraganglioma Syndrome Type 1
2008
·
Mariola Pęczkowska
, Zoran Erlic
, et al.
·
The Journal of Clinical Endocrinology & Metabolism
·
31
PDF
Efficacy and safety of a new intravenous immunoglobulin 10% formulation (octagam ® 10%) in patients with immune thrombocytopenia
2010
·
Tadeusz Robak
, Claudia Mainau
, et al.
·
Hematology
·
30
PDF
Effects of Rivaroxaban Therapy on ROTEM Coagulation Parameters in Patients with Venous Thromboembolism
2015
·
Krzysztof Chojnowski
, Tomasz Górski
, et al.
·
Advances in Clinical and Experimental Medicine
·
27
PDF
Assessment of rotation thromboelastometry (ROTEM) parameters in patients with multiple myeloma at diagnosis
2014
·
Jacek Treliński
, Małgorzata Misiewicz
, et al.
·
Thrombosis Research
·
26
Toxic epidermal necrolysis in a patient with severe aplastic anemia treated with cyclosporin A and G-CSF.
2001
·
E Robak
, T Robak
, et al.
·
PubMed
·
22
Plasma levels of angiogenic factors and circulating endothelial cells in essential thrombocythemia: correlation with cytoreductive therapy andJAK2–V617Fmutational status
2010
·
Jacek Treliński
, Agnieszka Wierzbowska
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
21
Successful treatment of refractory autoimmune thrombocytopenia with rituximab and cyclosporin A in a patient with chronic granulomatous disease
2005
·
Jacek Treliński
, Krzysztof Chojnowski
, et al.
·
Annals of Hematology
·
21
Determination and interpretation of MTHFR gene mutations in gynecology and internal medicine
2019
·
Anetta Undas
, Krzysztof Chojnowski
, et al.
·
Polskie Archiwum Medycyny Wewnętrznej
·
17
PDF
Assessment of Selected ROTEM Parameters, Kinetics of Fibrinogen Polymerization and Plasmin Amidolytic Activity in Patients with Congenital Fibrinogen Defects
2016
·
Jacek Treliński
, Katarzyna Pachniewska
, et al.
·
Advances in Clinical and Experimental Medicine
·
17
PDF
Część I: Wytyczne postępowania w hemofilii A i B niepowikłanej inhibitorem czynnika VIII i IX (wydanie zaktualizowane)
2016
·
Jerzy Windyga
, Krzysztof Chojnowski
, et al.
·
Acta Haematologica Polonica
·
15
Registry of inherited bleeding disorders in Poland – current status and potential role of the HemoRec database
2010
·
J. ZDZIARSKA
, K. CHOJNOWSKI
, et al.
·
Haemophilia
·
15
Impaired apoptosis of megakaryocytes and bone marrow mononuclear cells in essential thrombocythemia: correlation with JAK2V617F mutational status and cytoreductive therapy
2012
·
Jacek Treliński
, Krzysztof Chojnowski
, et al.
·
Medical Oncology
·
14
PDF
Efficacy and Safety of the New Intravenous Immunoglobulin IGIV 10% in Adults with Chronic Idiopathic Thrombocytopenic Purpura
2006
·
Gyula Varga
, Zuzana Volková
, et al.
·
Transfusion Medicine and Hemotherapy
·
14
Efficacy and toxicity of low-dose melphalan in myelodysplastic syndromes and acute myeloid leukemia with multilineage dysplasia.
2003
·
T Robak
, A Szmigielska-Kapłon
, et al.
·
PubMed
·
14
High activity of rituximab combined with cladribine and cyclophosphamide in a patient with pulmonary lymphomatoid granulomatosis and bone marrow involvement
2006
·
Tadeusz Robak
, Radzisław Kordek
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
13
Część II: Wytyczne postępowania w hemofilii A i B powikłanej inhibitorem czynnika VIII i IX (2 wydanie)
2017
·
Jerzy Windyga
, Krzysztof Chojnowski
, et al.
·
Acta Haematologica Polonica
·
10
Pro-Apoptotic Activity of Ruxolitinib Alone and in Combination with Hydroxyurea, Busulphan, and PI3K/mTOR Inhibitors in JAK2-Positive Human Cell Lines
2015
·
Joanna Szymańska
, Piotr Smolewski
, et al.
·
Advances in Clinical and Experimental Medicine
·
10
PDF
Show more works
View as search
Works count:
130
Citation count:
1,015
H-index:
17
I10-index:
26
Year
Topic
Type
